Volume 1 ; Issue 1 ; in Month : Jan-June (2026) Article No : 102
Md. Javed Karim, Basit Fazal

Abstract

Congestive Heart Failure (CHF) is a complex and progressive cardiovascular syndrome characterized by the heart's inability to pump blood efficiently, leading to insufficient perfusion of tissues and organs. This project critically examines the clinical, therapeutic, and pharmaceutical dimensions of CHF, emphasizing its growing impact on global and Indian healthcare systems. The pathophysiology involves neurohormonal activation, structural remodelling, and hemodynamic alterations, which contribute to hallmark symptoms such as dyspnoea, fatigue, and fluid retention. This study was conducted as a prospective observational analysis at a tertiary care hospital, evaluating 120 patients diagnosed with CHF. It incorporates data on demographic profiles, comorbidities, ejection fraction, drug utilization patterns, and adverse reactions. Pharmacological management included the use of ACE inhibitors, beta-blockers, diuretics, ARBs, MRAs, and emerging agents like ARNI and SGLT2 inhibitors. The findings revealed that pharmacist-led interventions significantly improved medication adherence (as measured by MMAS-8), reduced hospital readmission rates, and enhanced patients’ quality of life. The integration of pharmaceutical care into CHF management demonstrated a clear reduction in symptom burden and healthcare utilization. This report reinforces the necessity of a multidisciplinary approach—combining clinical precision with sustained patient education and counselling—to optimize outcomes. The results advocate for stronger policy support and wider implementation of pharmacist- driven models in chronic disease management, particularly in resource-limited settings.

Full Text Attachment

Views : 6      Downloads : 1

RSS